A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs
- PMID: 27307154
- PMCID: PMC5021755
- DOI: 10.1007/s40291-016-0217-0
A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs
Abstract
Thiopurine methyltransferase (TPMT) and inosine triphosphatase (ITPA) are crucial enzymes involved in the metabolism of thiopurine drugs: azathioprine and 6-mercaptopurine, used in the treatment of leukemia or inflammatory bowel diseases (IBD). The activity in these enzymes correlates with the genetic polymorphism of the TPMT and ITPA genes, respectively, which determines an individual reaction and dosing of thiopurines. Three main TPMT alleles: TPMT*2 (c.238G>C), TPMT*3A (c.460G>A, c.719A>G) and TPMT*3C (c.719A>G) account for 80-95 % of inherited TPMT deficiency in different populations in the world. In the ITPA gene, a c.94C>A mutation is significantly associated with an adverse thiopurine reaction. The aim of this study was to develop a quick and highly sensitive method for determining major TPMT and ITPA alleles. Here we present the molecular test for genotyping c.238G>C, c.460G>A, c.719A>G and c.94C>A changes based on multiplex high resolution melting analysis (HRMA). We analyzed DNA samples from 100 clinically diagnosed IBD patients treated with thiopurine drugs, and a known genotype in the positions 238, 460 and 719 of the TPMT gene as well as in position 94 of the ITPA gene. Our results obtained with multiplex HRMA indicated 100 % accuracy in comparison with data from restriction fragments length polymorphism (RFLP) and standard DNA sequencing. We conclude, that multiplex HRMA can be used as a quick, sensitive and efficient alternative diagnostic method compared to conventional techniques for the determination of TPMT*2, TPMT*3A and TPMT*3C alleles and c.94C>A change in the ITPA gene.
Conflict of interest statement
Compliance with Ethical StandardsConflict of interestThe authors MSZ, PB, ABK, OZB, MW, AD, MK, MW, DL, AP and RS declare no conflicts of interest.Ethical approval and informed consentAll patients declared informed consent and the studies were approved by the local Ethics Committee of the Poznan University of Medical Sciences (Approval No. 871/09).FundingThe studies was funded by a Grant from the Polish Ministry of Science and Higher Education (Grant No. N N402209835).
Figures


Similar articles
-
Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.Clin Gastroenterol Hepatol. 2006 Jan;4(1):44-9. doi: 10.1016/j.cgh.2005.10.019. Clin Gastroenterol Hepatol. 2006. PMID: 16431304
-
TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.Adv Med Sci. 2016 Mar;61(1):135-40. doi: 10.1016/j.advms.2015.09.008. Epub 2015 Dec 10. Adv Med Sci. 2016. PMID: 26674571
-
High-resolution melting analysis of the TPMT gene: a study in the Polish population.Genet Test Mol Biomarkers. 2013 Feb;17(2):153-9. doi: 10.1089/gtmb.2012.0192. Epub 2012 Dec 19. Genet Test Mol Biomarkers. 2013. PMID: 23252704 Free PMC article.
-
Clinical pharmacogenomics of thiopurine S-methyltransferase.Curr Clin Pharmacol. 2006 Jan;1(1):119-28. doi: 10.2174/157488406784111627. Curr Clin Pharmacol. 2006. PMID: 18666383 Review.
-
Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.Expert Opin Drug Saf. 2010 Jan;9(1):23-37. doi: 10.1517/14740330903426151. Expert Opin Drug Saf. 2010. PMID: 20021291 Review.
Cited by
-
Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.Clin Rheumatol. 2021 Jan;40(1):65-73. doi: 10.1007/s10067-020-05258-2. Epub 2020 Jul 2. Clin Rheumatol. 2021. PMID: 32617765 Free PMC article. Review.
-
Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values.BMC Res Notes. 2018 Feb 14;11(1):129. doi: 10.1186/s13104-018-3237-5. BMC Res Notes. 2018. PMID: 29444714 Free PMC article.
-
Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practice.Pharmacogenomics J. 2020 Oct;20(5):736-745. doi: 10.1038/s41397-020-0163-4. Epub 2020 Feb 14. Pharmacogenomics J. 2020. PMID: 32054992 Free PMC article.
-
High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype.J Gastroenterol. 2020 Jan;55(1):67-77. doi: 10.1007/s00535-019-01638-x. Epub 2019 Oct 22. J Gastroenterol. 2020. PMID: 31641873
-
Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians.Genes (Basel). 2017 Oct 23;8(10):285. doi: 10.3390/genes8100285. Genes (Basel). 2017. PMID: 29065511 Free PMC article.
References
-
- Lafolie P, Hayder S, Björk O, Ahström L, Liliemark J, Peterson C. Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukaemia and non-Hodgkin lymphoma. Acta Paediatr Scand. 1986;75(5):797–803. doi: 10.1111/j.1651-2227.1986.tb10293.x. - DOI - PubMed
-
- Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608–614. doi: 10.7326/0003-4819-126-8-199704150-00003. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous